
Your Feed
Who Holds the Key to a Myeloma Cure? A Thank You to Our Community.

Pre-diagnosis Dietary Patterns of Multiple Myeloma | Richa Parikh, MD | ASH 2023
The Evolving Landscape of Multiple Myeloma | Claudio Cerchione, MD, PhD | ASH 2023
Medical Writing Bias in Myeloma Clinical Research | James Berenson, MD | ASH 2023
Mezigdomide Plus Dexamethasone in RRMM: CC-92480-MM-002 Trial Results | Paul Richardson, MD | ASH 2023
Outcomes of Triple Class Refractory Multiple Myeloma Patients | James Berenson, MD | ASH 2023
Undetectable Circulating Tumor Cells in Myeloma Patients | Juan-José Garcés, PhD | ASH 2023
Triplet Therapy Determination Phase 3 Trial | Paul Richardson, MD | ASH 2023
Assessing Lenalidomide with Patients Progressing on JAK Inhibitors | James Berenson, MD | ASH 2023
BCMA and GPRC5D Targeted Therapy | Luciano Costa, MD, PhD | ASH 2023
Applying the EHA/EBMT Grading System for Icaht Following CAR-T Therapy | Kai Rejeski, MD | ASH 2023






